China Pharma Holdings (CPHI) Profit After Tax Growth (3y) (2013 - 2026)
China Pharma Holdings (CPHI) Profit After Tax Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.06 Bn | 87.19 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.92 Bn | 32.18 Bn | 1.97 Bn | 51.23% |
| 3 | Zoetis | 32.51 Bn | 30.57 Bn | 1.62 Bn | 2.94% |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.49 Bn | 4.39 Bn | -70.53% |
| 5 | United Therapeutics | 23.18 Bn | 21.03 Bn | 648.10 Mn | 4.50% |
| 6 | RedHill Biopharma | 21.76 Bn | 21.76 Bn | - | - |
| 7 | Viatris | 20.28 Bn | 18.48 Bn | 1.16 Bn | -7.75% |
| 8 | Neurocrine Biosciences | 17.75 Bn | 16.43 Bn | 800.70 Mn | 66.11% |
| 9 | Elanco Animal Health | 12.63 Bn | 12.21 Bn | 785.00 Mn | -17.90% |
| 10 | China Pharma Holdings | 30.72 Mn | 30.55 Mn | 285,487.00 | -14.24% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -14.24% |
| Dec 31, 2025 | 19.24% |
| Sep 30, 2025 | 9.09% |
| Jun 30, 2025 | 15.90% |
| Mar 31, 2025 | 8.62% |
| Dec 31, 2024 | -7.68% |
| Sep 30, 2024 | -5.85% |
| Jun 30, 2024 | -20.36% |
| Mar 31, 2024 | -7.60% |
| Dec 31, 2023 | 6.60% |
| Sep 30, 2023 | -12.96% |
| Jun 30, 2023 | -222.24% |
| Mar 31, 2023 | 10.36% |
| Dec 31, 2022 | 49.83% |
| Sep 30, 2022 | -4.10% |
| Jun 30, 2022 | -1.96% |
| Mar 31, 2022 | -35.08% |
| Dec 31, 2021 | 49.45% |
| Sep 30, 2021 | 37.54% |
| Jun 30, 2021 | 6.47% |